tradingkey.logo

AxoGen Inc

AXGN
查看詳細走勢圖
35.460USD
+0.440+1.26%
交易中 美東報價延遲15分鐘
1.64B總市值
虧損本益比TTM

AxoGen Inc

35.460
+0.440+1.26%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.26%

5天

+2.13%

1月

+14.39%

6月

+179.87%

今年開始到現在

+8.34%

1年

+94.73%

查看詳細走勢圖

TradingKey AxoGen Inc股票評分

單位: USD 更新時間: 2026-02-02

操作建議

AxoGen Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名3/206位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為36.60。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

AxoGen Inc評分

相關信息

行業排名
3 / 206
全市場排名
44 / 4529
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

AxoGen Inc亮點

亮點風險
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
業績高增長
公司營業收入穩步增長,連續3年增長35.18%
估值低估
公司最新PE估值-837.40,處於3年歷史低位
機構加倉
最新機構持股42.08M股,環比增加0.02%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉2.15K股
活躍度增加
近期活躍度增加,過去20天平均換手率2.01

分析師目標

基於 10 分析師
買入
評級
36.600
目標均價
+5.02%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

AxoGen Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

AxoGen Inc簡介

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
公司代碼AXGN
公司AxoGen Inc
CEODale (Michael Donald)
網址https://www.axogeninc.com/
KeyAI